SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-20-329883
Filing Date
2020-12-30
Accepted
2020-12-30 16:40:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d170965dsc13d.htm SC 13D 49532
  Complete submission text file 0001193125-20-329883.txt   50901
Mailing Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054
Business Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054 650-800-6676
Vincera Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91457 | Film No.: 201426328
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Byrd John C. (Filed by) CIK: 0001835066 (see all company filings)

Type: SC 13D